EMERALD ADVISERS, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$25,411,000
+15.5%
485,954
-4.0%
0.93%
+12.5%
Q2 2018$22,009,000
-15.4%
506,424
-27.9%
0.83%
-20.4%
Q1 2018$26,024,000
+81.8%
702,399
-2.6%
1.04%
+89.3%
Q4 2017$14,313,000
-21.1%
721,438
-1.0%
0.55%
-25.3%
Q3 2017$18,131,000
+46.3%
728,433
+2.5%
0.74%
+42.5%
Q2 2017$12,390,000710,4560.52%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders